AFLAC (NYSE:AFL) updated its FY20 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $4.35-4.50 for the period, compared to the Thomson Reuters consensus estimate of $4.46. AFLAC also updated its FY 2020
Pre-Market guidance to 4.30-4.50 EPS.
AFL has been the subject of a number of recent analyst reports. Bank of America set a $55.00 price objective on AFLAC and gave the company a hold rating in a research report on Friday, October 25th. Barclays decreased their target price on AFLAC from $53.00 to $49.00 and set an equal weight rating on the stock in a report on Friday, August 23rd. Finally, UBS Group increased their price target on AFLAC from $51.00 to $53.00 and gave the company a neutral rating in a research note on Thursday, October 10th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the company. The company presently has a consensus rating of Hold and a consensus target price of $53.73.
Shares of AFL stock opened at $52.68 on Tuesday. AFLAC has a 52 week low of $41.88 and a 52 week high of $57.18. The company has a market capitalization of $40.25 billion, a price-to-earnings ratio of 12.66, a PEG ratio of 2.94 and a beta of 0.71. The company has a 50-day simple moving average of $53.64 and a 200 day simple moving average of $53.13. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.05 and a current ratio of 0.05.
The company also recently announced a quarterly dividend, which was paid on Monday, December 2nd. Stockholders of record on Wednesday, November 20th were given a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 2.05%. The ex-dividend date of this dividend was Tuesday, November 19th. AFLAC’s payout ratio is 25.96%.
In other news, Director Toshihiko Fukuzawa sold 1,500 shares of AFLAC stock in a transaction on Friday, September 27th. The stock was sold at an average price of $52.00, for a total transaction of $78,000.00. Following the completion of the sale, the director now owns 11,349 shares of the company’s stock, valued at $590,148. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Karole Lloyd bought 1,000 shares of the company’s stock in a transaction dated Thursday, November 7th. The shares were purchased at an average cost of $54.08 per share, with a total value of $54,080.00. Following the acquisition, the director now directly owns 28,181 shares of the company’s stock, valued at approximately $1,524,028.48. The disclosure for this purchase can be found here. 1.30% of the stock is currently owned by company insiders.
AFLAC Company Profile
Aflac Incorporated, through its subsidiaries, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.
See Also: Why is the LIBOR significant?
Receive News & Ratings for AFLAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AFLAC and related companies with MarketBeat.com's FREE daily email newsletter.